Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H9F3N2O2 |
Molecular Weight | 270.2073 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
InChI
InChIKey=VHOGYURTWQBHIL-UHFFFAOYSA-N
InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)
Molecular Formula | C12H9F3N2O2 |
Molecular Weight | 270.2073 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:32:43 UTC 2023
by
admin
on
Fri Dec 15 15:32:43 UTC 2023
|
Record UNII |
G162GK9U4W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
LEFLUNOMIDE RATIOPHARM (AUTHORIZED: ARTHITIS, RHEUMATOID)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
89895
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LEFLUNOMIDE WINTHROP (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
NCI_THESAURUS |
C1971
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ARAVA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
LIVERTOX |
NBK548725
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
NCI_THESAURUS |
C1557
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
NCI_THESAURUS |
C2169
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ARAVA (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LEFLUNOMIDE TEVA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
WHO-ATC |
L04AA13
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
WHO-VATC |
QL04AA13
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
100296
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
REPSO (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
REPSO (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LEFLUNOMIDE WINTHROP (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LEFLUNOMIDE MEDAC (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
95095
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
||
|
NDF-RT |
N0000175713
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
75706-12-6
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
5079
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
100000085463
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
27169
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | RxNorm | ||
|
759864
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
DB01097
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
C045463
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
7289
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
DTXSID9023201
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
KK-119
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
1552
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
C1128
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
G162GK9U4W
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
Leflunomide
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
m6756
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | Merck Index | ||
|
G162GK9U4W
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
1356960
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
6402
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
6825
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL960
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
SUB08424MIG
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
LEFLUNOMIDE
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
3899
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY | |||
|
677411
Created by
admin on Fri Dec 15 15:32:43 UTC 2023 , Edited by admin on Fri Dec 15 15:32:43 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
Leflunomide is metabolized to one primary (M1) and many minor metabolites. Of these minor metabolites, only 4-trifluoromethylaniline (TFMA) is quantifiable
MINOR
PLASMA
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |